New study reveals mast cells’ surprising role in allergy-related avoidance behavior

FHS
July 14, 2023
10:37 am

Researchers showed that mast cells and IgE are the key orchestrators of antigen-specific avoidance.

Wave’s new capital extends cash runway into 2027, CEO says

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 3, 2024

Biotech Bonanza 2023 Biotech OutlookAs The FED Remains Hawkish • Prudent Biotech

Federal Reserve interest rate policy to again remain the market focus this year and create a chaotic first half. Biotechs should be favorably positioned relative

January 10, 2023

Gilead concludes acquisition of CymaBay Therapeutics for $4.3bn

Share this article The merger positioned Gilead to integrate CymaBay’s investigational lead product candidate, seladelpar, into its portfolio. Credit: Sundry Photography / Shutterstock.com. Gilead Sciences

March 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.